Frazier Life Sciences Management, L.P.: PALVELLA THERAPEUTICS INC NE (PVLA): Quarterly 13F Position History
As of Q2 2026, Frazier Life Sciences Management, L.P. reported 882,400 shares of PALVELLA THERAPEUTICS INC NE (PVLA), worth $134.8M and representing 2.9% of its 13F equity book. The position first appeared in Q4 2024 and has been disclosed across 7 13F-HR filings in Pactolio's tracked window.
- 882,400Shares Held (Latest Filing)
- $134.8MReported Market Value (Latest Filing)
- 2.9%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- +$24.9MQuarter-over-Quarter Value Change
- 882,400Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 882,400 | 0 | – | $134.8M | 2.9% | $152.8 |
| Q1 2026 | 882,400 | +160,000 | +22.1% | $110.0M | 2.8% | $124.7 |
| Q4 2025 | 722,400 | 0 | – | $75.6M | 2.0% | $104.7 |
| Q3 2025 | 722,400 | 0 | – | $45.3M | 1.4% | $62.7 |
| Q2 2025 | 722,400 | +32,388 | +4.7% | $16.3M | 0.7% | $22.5 |
| Q1 2025 | 690,012 | +36,120 | +5.5% | $19.3M | 0.9% | $28.0 |
| Q4 2024 | 653,892 | – | – | $7.8M | 0.3% | $12.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Frazier Life Sciences Management, L.P. first disclose a PVLA position in 13F-HR filings?
Frazier Life Sciences Management, L.P. first reported PALVELLA THERAPEUTICS INC NE (PVLA) on its 13F-HR filing for the period ending 2024-12-31 (Q4 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.
What was Frazier Life Sciences Management, L.P.'s most recent quarter-over-quarter share-count change in PVLA?
Frazier Life Sciences Management, L.P. held the same 882,400 shares of PVLA between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Frazier Life Sciences Management, L.P.'s cost basis in PVLA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.